Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib

Ian J. Griswold, Mary MacPartlin, Thomas Bumm, Valerie L. Goss, Thomas O'Hare, Kimberly A. Lee, Amie S. Corbin, Eric P. Stoffregen, Caitlyn Smith, Kara Johnson, Erika M. Moseson, Lisa J. Wood, Roberto D. Polakiewicz, Brian J. Druker, Michael W. Deininger

Research output: Contribution to journalArticlepeer-review

166 Scopus citations

Fingerprint

Dive into the research topics of 'Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences